Key Takeaways
- SPCX shares finished Friday’s session down 1% at $152.71, even with a substantial $946 million NASA contract win.
- The space company secured three additional Commercial Crew missions from NASA, expanding its program portfolio to 17 flights valued at $5.92 billion.
- The highly anticipated Starship Flight 14 mission has been rescheduled from September 22 to September 28, subject to regulatory clearance.
- Second-quarter revenue reached $7.81 billion, representing a 92% year-over-year surge.
- Technical analysts at Invezz have identified an ascending triangle pattern, while analyst consensus targets $221.42.
Shares of SpaceX (SPCX) finished Friday’s trading session at $152.71, declining 1.36% after fluctuating within a $149.93 to $156.60 range throughout the day. The current price sits significantly higher than the 2026 low of $104.83.
Space Exploration Technologies Corp., SPCX
The modest decline occurred despite positive news from NASA, which expanded SpaceX’s Commercial Crew program with three additional astronaut transportation missions valued at $946 million.
According to NASA’s announcement, the newly awarded missions are designated as Crew-15, Crew-16, and Crew-17. This expansion brings SpaceX’s total contracted mission count under the program to 17 flights.
The contract modification encompasses comprehensive services including ground operations, launch procedures, orbital operations, spacecraft return and recovery, cargo delivery capabilities, and emergency evacuation functions. NASA confirmed the program’s cumulative value now reaches $5.92 billion.
Expanded NASA Partnership Strengthens Revenue Pipeline
The extended agreement stretches through 2030, with mission readiness milestones scheduled between 2027 and 2028. SpaceX initially received NASA certification for crewed spaceflight operations in November 2020.
This contract extension follows SpaceX’s announcement of $7.81 billion in second-quarter revenue. The figure represents a 91.9% increase compared to the corresponding quarter in the previous year, based on MarketBeat data.
The company posted a quarterly loss of $0.09 per stock unit, which exceeded analyst expectations of a $0.26 loss. Despite improved performance, SpaceX continues to operate at a loss on an earnings-per-share basis.
Institutional investment activity remains robust. Corient Private Wealth established a new position valued at approximately $5.09 million through the acquisition of 29,814 SPCX stock units in the second quarter.
MarketBeat’s compilation shows 26 Buy ratings, eight Hold ratings, and seven Sell ratings among Wall Street analysts covering SpaceX. The consensus price target of $221.42 implies approximately 45% upside from Friday’s closing level.
Starship Flight 14 Delay Creates Near-Term Uncertainty
Investor attention now shifts to Starship Flight 14, SpaceX’s upcoming milestone mission. The company rescheduled the planned launch from September 22 to September 28, pending final regulatory authorization.
This mission represents a significant milestone as it aims to complete Starship’s inaugural orbital flight. The flight plan includes approximately six complete Earth orbits over a mission duration approaching 10 hours.
Additionally, SpaceX intends to deploy 26 Starlink V3 satellites during the mission. These advanced satellites are engineered to deliver one terabit per second of network throughput each.
The six-day postponement contributed to Friday’s negative price action for SPCX shares. SpaceX has not issued a public statement explaining the schedule adjustment.
From a technical analysis standpoint, Invezz has identified an ascending triangle formation on the two-hour timeframe chart. The analysis also notes that SPCX continues trading above its 50-period moving average, with $200 representing a potential breakout threshold.
SPCX has appreciated from approximately $104.60 in August to current levels exceeding $150. The 50-day moving average currently resides near $134.69, according to MarketBeat.
Looking ahead, the September 28 Starship launch represents the nearest catalyzing event for market participants to monitor. SpaceX maintains that the mission timeline depends entirely on receiving regulatory authorization.





